| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.00023 | 1 |